AQP1 has been identified as an emerging protein involved in the pathophysiology of myocardial edema, coronary atherosclerosis [58] and also DCM, where its expression was found to be detrimentally reduced in high glucose-evoked cardiomyocyte injury [61]. Here, AQP1 is linked to familial dilated cardiomyopathy.